TECH WHO announces three new drugs for latest COVID-19 clinical trials


WHO announces three new drugs for latest COVID-19 clinical trials


17:31, August 12, 2021

File photo: CFP

Three new candidate drugs are being tested in the latest phase of global solidarity clinical trials to find effective treatments against COVID-19, the World Health Organization (WHO) on announced on Wednesday.

The three drugs – artesunate, imatinib and infliximab – will be tested on hospitalized COVID-19 patients across 52 countries under the Solidarity PLUS program.

The announcement comes as the number of COVID-19 infections globally have surpassed the 204.28 million mark, with deaths exceeding 4.31 million.

"We already have many tools to prevent, test for and treat COVID-19, including oxygen, dexamethasone and IL-6 blockers. But we need more, for patients at all ends of the clinical spectrum, from mild to severe disease. And we need health workers that are trained to use them in a safe environment," the WHO Director-General Tedros Adhanom said at a press conference in Geneva.

The three drugs were selected by an independent panel for their potential in reducing the risk of death in people hospitalized for COVID-19.

They are already being used to treat other conditions.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue